Tabelecleucel
id:
tabelecleucel-307-18558342
title:
Tabelecleucel
text:
Tabelecleucel, sold under the brand name Ebvallo, is a medication used for the treatment of Epstein-Barr virus positive post-transplant lymphoproliferative disease. Tabelecleucel is an allogeneic, EBV-specific T-cell immunotherapy which targets and eliminates EBV-infected cells in a human leukocyte antigen (HLA)-restricted manner. It is made of cells of the immune system called T-cells that have been taken from the recipient (allogeneic) and are then mixed with EBV-infected B-cells from the same
brand slug:
wiki
category slug:
encyclopedia
description:
Immunotherapy
original url:
https://en.wikipedia.org/wiki/Tabelecleucel
date created:
date modified:
2023-12-18T06:36:31Z
main entity:
{"identifier":"Q114749444","url":"https://www.wikidata.org/entity/Q114749444"}
image:
fields total:
13
integrity:
14